Elevance Health (ELV) vs Labcorp (LH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Labcorp (LH) has outperformed Elevance Health (ELV) over the past year, gaining 13.2% versus a gain of 10.7%. Over five years, LH leads with a +34.7% price change compared with +2.9% for ELV. Elevance Health is the larger company by market cap ($86.95 billion vs $25.48 billion), about 3.4 times the size.
On valuation, Elevance Health trades at a lower forward P/E (13.6x vs 15.9x for Labcorp). Elevance Health offers the higher dividend yield (1.71% vs 0.92%). Labcorp converts more of its revenue into profit, with a net margin of 6.3% versus 2.8%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELV | LH |
|---|---|---|
| Share price | $400.94 | $314.20 |
| Market cap | $86.95B | $25.48B |
| 1-day change | -0.83% | +0.71% |
| YTD return | +14.37% | +25.24% |
| 1-year return | +10.65% | +13.22% |
| 5-year return | +2.86% | +34.66% |
| P/E ratio (TTM) | 17.75 | 25.99 |
| Forward P/E | 13.55 | 15.86 |
| EPS (TTM) | $22.59 | $12.09 |
| Dividend yield | 1.71% | 0.92% |
| Annual dividend | $6.86 | $2.88 |
| Revenue (latest FY) | $199.13B | $13.95B |
| Revenue growth (YoY) | +12.49% | +7.25% |
| Net income (latest FY) | $5.66B | $876.50M |
| Gross margin | 89.36% | 28.76% |
| Operating margin | 3.62% | 9.92% |
| Net margin | 2.84% | 6.28% |
| 52-week high | $436.24 | $341.80 |
| 52-week low | $274.84 | $244.52 |
| Distance from 52-week high | -8.09% | -8.07% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +12.61% | +9.54% |
| Average volume | 1.19M | 742.58K |
| Shares outstanding | 216.87M | 81.10M |
| Employees | 96,129 | 71,000 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Elevance Health is about 3.4 times larger than Labcorp by market value ($86.95B vs $25.48B).
- Labcorp trades at a higher earnings multiple (26.0x vs 17.7x trailing P/E).
- Elevance Health grew revenue faster in its latest fiscal year (+12.49% vs +7.25%).
About Elevance Health
ELV stock →Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.
Health Care · Medical Specialities · 96,129 employees
About Labcorp
LH stock →Labcorp Holdings Inc. provides laboratory services.
Health Care · Medical Specialities · 71,000 employees
ELV vs LH FAQ
Which is bigger, Elevance Health or Labcorp?
Elevance Health (ELV) is larger, with a market capitalization of $86.95B compared with $25.48B for Labcorp (LH).
Which stock has performed better over the past year, ELV or LH?
LH returned +13.22% over the past 12 months, compared with +10.65% for ELV (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ELV or LH?
ELV has the lower trailing P/E at 17.7, versus 26.0 for LH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Elevance Health or Labcorp?
Elevance Health has the higher yield at 1.71%, compared with 0.92% for Labcorp.
Are Elevance Health and Labcorp in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.